This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
RABBIT ANTI HUMAN CD262
catalog :
AHP488
quantity :
0.1 mg
price :
371 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
Entity Type :
Polyclonal Antibody
Entity Category :
Antibodies
ProductCode :
AHP488
Description :
RABBIT ANTI HUMAN CD262
Specificity :
CD262
TargetSpecies :
Human
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
WB,C
ApplicationTypes :
Western Blotting,Immunohistology - Frozen
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0008656,GO:0008633,GO:0008625,GO:0007250,GO:0007166,GO:0006919,GO:0004872,GO:0016021,GO:0045569,GO:0043123,GO:0005886
GOTerms :
bacterial inner membrane,cell membrane,cytoplasmic membrane,GO:0005904,inner endospore membrane,juxtamembrane,plasma membrane lipid bilayer,plasmalemma,transmembrane,GO:0019041,receptor guanylate cyclase activity,viral antireceptor activity,caspase activation,cell surface receptor linked signal transduction,cell surface receptor linked signalling pathway,positive regulation of NF-kappaB-inducing kinase activity,induction of apoptosis via death receptors,induction of pro-apoptotic gene products,activation of I-kappaB kinase/NF-kappaB cascade,stimulation of I-kappaB kinase/NF-kappaB cascade,up regulation of I-kappaB kinase/NF-kappaB cascade,up-regulation of I-kappaB kinase/NF-kappaB cascade,upregulation of I-kappaB kinase/NF-kappaB cascade,Apo-2L binding
Uniprot Accessions :
O14763
Gene :
TNFRSF10B
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8795
Published Synonyms :
DR5,TRAIL-R2
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 0.5mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
265
PriceEUR :
371
PriceUSD :
371 USD
PriceCHF :
404
PriceSEK :
4044
PriceNOK :
4064
PriceDKK :
2766
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments